Phase II Trial of Oral Altretamine for Consolidation of Clinical Complete Remission in Women with Stage III Epithelial Ovarian Cancer: A Southwest Oncology Group Trial (SWOG-9326)

Author: Rothenberg M.L.   Liu P.Y.   Wilczynski S.   Hannigan E.V.   Weiner S.A.   Weiss G.R.   Hunter V.J.   Chapman J.A.   Tiersten A.   Kohler P.C.   Alberts D.S.  

Publisher: Elsevier

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.82, Iss.2, 2001-08, pp. : 317-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content